Should You Buy Becton Dickinson and Co (BDX) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
BUY for a beginner long-term investor with $50k–$100k who wants to act now. BDX is in a broadly bullish longer-term trend (moving averages stacked bullish) and has near-term shareholder-friendly catalysts (dividend + expanded buyback) plus a major corporate event (spin/merger closing early Feb). While momentum is slightly soft in the very short term (negative MACD histogram), the setup still favors owning now for long-term compounding rather than waiting for a perfect dip.
Technical Analysis
Price/Trend: BDX at ~$204 is sitting just above the pivot support area (Pivot 203.254), with the next resistance around 208.464 then 211.684. Trend structure is constructive because SMA_5 > SMA_20 > SMA_200 (bullish alignment), typically consistent with an uptrend/healthy longer-term bias.
Momentum: MACD histogram is -0.428 and negatively expanding, implying near-term momentum has weakened and the stock could chop or pull back modestly before resuming.
RSI: RSI(6) ~48 is neutral—no clear overbought/oversold condition.
Practical read: Long-term trend is favorable, but near-term price action is likely range-bound between ~198 support (S1) and ~208 resistance (R1) unless a catalyst (earnings/spin news) breaks it out.
Analyst Ratings and Price Target Trends
Recent trend: Price targets have generally been raised into late Jan 2026 (e.g., Piper Sandler to $205 from $190; BofA to $207 from $190; RBC to $210; Morgan Stanley to $210; Stifel to $215). Ratings are mixed but skew constructive: some Neutrals/Sector Perform alongside Overweight/Buy.
Wall Street ‘Pros’ view: Durable recurring-revenue MedTech core, supportive sector fundamentals (demographics, healthcare access), and potential for cleaner story/valuation after business reporting changes and the pending transaction.
Wall Street ‘Cons’ view: Expectations tempered by prior FY26 guidance reset and noted headwinds (certain product comps/geographies), which is why several firms remain Neutral despite target bumps.
Influential/politician trading: No recent congress trading data available in the last 90 days; no politician activity provided.
**Intellectia Proprietary Trading Signals**
- [AI Stock Picker](module://ai_stock_pick): no signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.
Wall Street analysts forecast BDX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BDX is 202.38 USD with a low forecast of 183 USD and a high forecast of 220 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast BDX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BDX is 202.38 USD with a low forecast of 183 USD and a high forecast of 220 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 201.920
Current: 201.920
